| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/17/2005 | CA2535517A1 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | CA2534971A1 5'-and 3'-capped aptamers and uses therefor |
| 02/17/2005 | CA2534909A1 P16 mediated regulation of nmda receptors |
| 02/17/2005 | CA2534899A1 Polypeptides having brain-localizing activity and uses thereof |
| 02/17/2005 | CA2534894A1 Fungus resistant plants and their uses |
| 02/17/2005 | CA2534812A1 Mutations in ion channels |
| 02/17/2005 | CA2534739A1 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 02/17/2005 | CA2534708A1 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 02/17/2005 | CA2534661A1 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | CA2534481A1 Ubiquitin-specific protease |
| 02/17/2005 | CA2534352A1 Methods of protein production in yeast |
| 02/17/2005 | CA2534296A1 Methods and compositions for targeted cleavage and recombination |
| 02/17/2005 | CA2534289A1 Method for the production of stably transformed, fertile gramineae employing agrobacterium-mediated transformation of isolated gramineae zygotes |
| 02/17/2005 | CA2533860A1 Moss expressing promoting regions |
| 02/17/2005 | CA2533557A1 Novel peptide interacting with anti-apoptotic proteins of a bcl-2 family |
| 02/17/2005 | CA2532759A1 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 02/17/2005 | CA2532312A1 Process for the production of fine chemicals in plants |
| 02/17/2005 | CA2531916A1 Animal model for the analysis of tumor metastasis |
| 02/17/2005 | CA2531773A1 Novel multifunctional cytokines |
| 02/17/2005 | CA2531228A1 Novel therapeutic fusion proteins |
| 02/17/2005 | CA2531119A1 Qtl "mapping as-you-go" |
| 02/17/2005 | CA2528510A1 Conserved hbv and hcv sequences useful for gene silencing |
| 02/17/2005 | CA2526900A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 02/17/2005 | CA2526274A1 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 02/17/2005 | CA2524767A1 Cyclodextrin affinity purification |
| 02/17/2005 | CA2517394A1 Recombinant human metapneumovirus and its use |
| 02/17/2005 | CA2502148A1 Methods and compositions for increasing the efficacy of biologically-active ingredients |
| 02/16/2005 | EP1507145A1 Biomolecular substrate, method of testing or diagnosis with use thereof and apparatus therefor |
| 02/16/2005 | EP1507011A1 PCR primer set for detecting hepatitis B virus, method for detecting hepatitis b using the primer set, and hepatitis b virus detection kit including the primer set |
| 02/16/2005 | EP1507010A2 Control of the gene expression in eukaryotic cells |
| 02/16/2005 | EP1507009A1 Vector for gene silencing and gene silencing method using the same |
| 02/16/2005 | EP1507008A2 Nucleotide sequences which code for the sahH gene |
| 02/16/2005 | EP1507007A1 Cell cycle related proteins |
| 02/16/2005 | EP1507006A1 Method of screening remedy for renal failure |
| 02/16/2005 | EP1507005A2 Antisense modulation of BCL-X expression |
| 02/16/2005 | EP1507004A1 Method to inhibit the propagation of an undesired cell population |
| 02/16/2005 | EP1507003A1 Process for producing protein in cell-free protein synthesis system using thioredoxin fused protein expression vector |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1507000A2 A thermostable ligase mediated DNA amplification system for the detection of genetic diseases |
| 02/16/2005 | EP1506995A1 Method of effecting lysis of acid-fast bacteria and method of performing gene amplification or detection therewith |
| 02/16/2005 | EP1506971A1 Prokineticin polypeptides, related compositions and methods |
| 02/16/2005 | EP1506784A1 Identification of novel factors that block programmed cell death or apoptosis by targeting JNK |
| 02/16/2005 | EP1506413A2 Automated system for isolating, amplyifying and detecting a target nucleic acid sequence |
| 02/16/2005 | EP1506411A1 Method for identifying type-i interferon responsive ms patients by determining trail expression |
| 02/16/2005 | EP1506409A1 Assays for modulators of asparaginyl hydroxylase |
| 02/16/2005 | EP1506408A2 Methods for diagnosing htlv-i-mediated diseases |
| 02/16/2005 | EP1506318A2 Methods and compositions for regulation and manipulation of steroidogenesis |
| 02/16/2005 | EP1506317A2 Marker molecules associated with lung tumors |
| 02/16/2005 | EP1506316A1 Method for improving efficiencies in livestock production |
| 02/16/2005 | EP1506315A2 Method of identifying pancreatic ductal carcinoma (pdc) specific genes using pancreatic ductal cells, method of testing for pdc using said genes, and method of screening pharmaceutical candidate compounds for treating or preventing pdc |
| 02/16/2005 | EP1506306A2 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling |
| 02/16/2005 | EP1506305A2 Dna and amino acid sequences of a tyrosine-inducible tyrosine ammonia lyase enzyme from the yeast trichosporon cutaneum |
| 02/16/2005 | EP1506303A2 Enzymes |
| 02/16/2005 | EP1506301A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 02/16/2005 | EP1506300A2 Genes and uses thereof to modulate secondary metabolite biosynthesis |
| 02/16/2005 | EP1506299A2 Method for producing a transgenic plant having modified transport of substances |
| 02/16/2005 | EP1506298A1 Engineered yeast cells for producing recombinant proteins |
| 02/16/2005 | EP1506297A2 Brachyspira hyodysenteriae vaccine |
| 02/16/2005 | EP1506296A1 A repressor-mediated regulation system for control of gene expression in plants |
| 02/16/2005 | EP1506295A2 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/16/2005 | EP1506294A1 Hydantoin racemase |
| 02/16/2005 | EP1506293A2 Microbial conversion of glucose to para-hydroxystyrene |
| 02/16/2005 | EP1506292A1 Pectate lyase variants |
| 02/16/2005 | EP1506291A2 Novel phospholipases and uses thereof |
| 02/16/2005 | EP1506289A2 Methods for increasing oil content in plants |
| 02/16/2005 | EP1506287A2 Methods of adenovirus purification |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP1506285A2 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 02/16/2005 | EP1506235A1 Method for producing monoclonal antibodies |
| 02/16/2005 | EP1506226A2 Use of the repressor glxr for the synthesis of lysine in corynebacterium glutamicum |
| 02/16/2005 | EP1506225A2 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus |
| 02/16/2005 | EP1506224A1 Polypeptide antigen inducing hiv neutralizing antibodies |
| 02/16/2005 | EP1506223A1 Fusion protein of hiv regulatory/accessory proteins |
| 02/16/2005 | EP1506222A2 Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide, virus-like particles prepared therefrom and a method for preparing the particles |
| 02/16/2005 | EP1506216A2 Antisense moodulation of kinesin-like 1 expression |
| 02/16/2005 | EP1506215A2 Novel polypeptides having sequence similarity to gdnfr and nucleic acids encoding the same |
| 02/16/2005 | EP1506021A2 Novel use of adenoviruses and nucleic acids coding therefor |
| 02/16/2005 | EP1506020A2 Processes for inhibiting gene expression using polynucleotides |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1506010A2 Methylated immunostimulatory oligonucleotides and methods of using the same |
| 02/16/2005 | EP1506009A2 Glucan-based vaccines |
| 02/16/2005 | EP1506001A2 Methods and compositions for treating vaginal, cervical, and uterine epithelial lesions |
| 02/16/2005 | EP1505942A2 Pathogen vaccines and methods for using the same |
| 02/16/2005 | EP1505871A2 Preservation of rna and morphology in cells and tissues |
| 02/16/2005 | EP1440081A4 Beta 2 adrenergic polymorphism detection |
| 02/16/2005 | EP1436391A4 Low-temperature cycle extension of dna with high priming specificity |
| 02/16/2005 | EP1414957A4 Vascular tissue preferred promoters |
| 02/16/2005 | EP1390433B1 Synthesis and evaluation of new cyanine dyes as minor groove of poly(da-dt)] 2 binders |
| 02/16/2005 | EP1373473A4 Gene targeting methods and vectors |
| 02/16/2005 | EP1304915A4 Modification of lignin biosynthesis |
| 02/16/2005 | EP1272627B1 Method and apparatus for plasmid recovery involving ultrafiltration |
| 02/16/2005 | EP1242442A4 Process for the scaleable purification of plasmid dna |
| 02/16/2005 | EP1161548B1 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/16/2005 | EP1114173A4 Synthesis of vanillin from a carbon source |
| 02/16/2005 | EP1093524B1 Recombinant herpes viruses for preparing recombinant adeno-associated viruses |
| 02/16/2005 | EP1017847B1 Method of mapping restriction sites in polynucleotides |
| 02/16/2005 | EP0963376B1 Prokaryotic two-hybrid system |
| 02/16/2005 | EP0958376B1 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 02/16/2005 | EP0957926B1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |